Late Breaking Abstract - Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry demonstrates inhaled drug deposition in transbronchial cryobiopsy samples of patients with Interstitial Lung Disease (ILD)

T. Mikolasch (London, United Kingdom), P. Marshall (Stevenage, United Kingdom), E. Oballa (Stevenage, United Kingdom), M. Vahdati-Bolouri (Stevenage, United Kingdom), J. Morell (Stevenage, United Kingdom), E. Jarvis (Stevenage, United Kingdom), Y. Cui (Stevenage, United Kingdom), A. Cahn (Stevenage, United Kingdom), J. Porter (London, United Kingdom)

Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings

Session: Idiopathic pulmonary fibrosis and surroundings
Session type: Oral Presentation
Number: 245

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Mikolasch (London, United Kingdom), P. Marshall (Stevenage, United Kingdom), E. Oballa (Stevenage, United Kingdom), M. Vahdati-Bolouri (Stevenage, United Kingdom), J. Morell (Stevenage, United Kingdom), E. Jarvis (Stevenage, United Kingdom), Y. Cui (Stevenage, United Kingdom), A. Cahn (Stevenage, United Kingdom), J. Porter (London, United Kingdom). Late Breaking Abstract - Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry demonstrates inhaled drug deposition in transbronchial cryobiopsy samples of patients with Interstitial Lung Disease (ILD). 245

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Confocal Laser Endomicroscopy (CLE) as a Guidance Tool for Transbronchial Lung Cryobiopsies in ILD Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018
Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020
Usefulness of electronic nose in detection of Interstitial Lung Diseases (ILD) Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD) Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018
Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017
Titel: MicroRNA analysis in Epithelial Lining Fluid (ELF) compared to Bronchoalveolar Lavage (BAL) in Interstitial pulmonary fibrosis (IPF) Source: International Congress 2014 – IPF and surroundings Year: 2014
Late Breaking Abstract - Transbronchial lung cryobiopsy for interstitial lung disease diagnosis: results of the COLDICE Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019
Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019
Transbronchial Lung Cryobiopsy (TBLC) for Interstitial Lung Disease (ILD) can be safely done in patients with multiple medical comorbidities Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study Source: International Congress 2014 – IPF and surroundings Year: 2014
Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021
Gender perspective in Interstitial Lung Diseases (ILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS Source: International Congress 2014 – ILDs 4 Year: 2014
Sarcoidosisandpulmonarydust: Mineralogical analysis (MA) and optical microscopy (OM) Source: International Congress 2014 – Sarcoidosis Year: 2014
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019